Next Phase Newsletter

By Antoinette Lowre, Manager of Business Development, LSN

Life Science Nation (LSN)’s RESI conference series is one of the only early-stage focused partnering experiences in the life science and healthcare ecosystem. All players use RESI to rally their partnership and fundraising goals. Sponsoring RESI is the fast-track to reaching these goals.

Benefits of sponsoring a RESI conference include increasing global brand and reach, sourcing, vetting and developing key relationships with your target audience, showcase your product and services through workshops and panels, and use our one-of-a-kind match-based partnering platform to connect with strategic partners and build relationships.

Check out our Sponsorship Brochure to meet your goals and reach your intended audience. Contact your BD rep to learn more on how to sponsor and gain visibility at Digital RESI, November 15-16, 2022 and RESI San Francisco, January 10-12, 2023

By Greg Mannix, Vice President International Business Development, General Manager Europe, LSN

If the pandemic taught us anything, it is that there is more than one way to skin a cat. Making connections and doing business while being hundreds or thousands of miles apart from our counterparts seemed like a ridiculous proposition only a few years ago, but alas! Nobody thinks that way today.

In fact, the RESI conference successfully created a digital platform for exactly that: making connections and doing business. Early-stage companies, investors, strategics and service providers discovered how to make the best of the situation and be very productive. The usefulness of remote, virtual meetings is evident today and will likely be around for the foreseeable future. But we saw last month at RESI Boston that there is a real desire to return to face-to-face gatherings.

While virtual meetings will continue to be useful, the return to in-person partnering conferences like RESI Boston and the upcoming RESI San Francisco, January10-12 have important advantages:

• Ad-hoc meetings throughout the day
• Networking receptions
• The undeniable power of a handshake (or elbow bump!)

To that end, any company in the early-stage life sciences arena must have JPM week in January in San Francisco on their radar. It’s the week that thousands of relevant investors, strategic partners and new technology startups converge on the City by the Bay to look for opportunities to connect and do business. Apart from scheduling planned meetings throughout the week, every evening is full of networking events to make more connections. It can be the most productive week of the year for many companies!

RESI San Francisco,, January 10-12, 2023 is a key part of JPM week. For early-stage players, it is, without a doubt, the best venue to identify and meet 500+ global investors and strategic partners. The RESI Partnering Platform allows you to schedule multiple meetings with the right counterparts on January 10. For the following two days, you can schedule both virtual and in-person meetings anywhere in the city using the RESI Partnering Platform.

As a lead-up to JPM week, LSN is offering a Digital RESI, November 15-16 partnering event. You can meet virtually with 200+ investors and strategics to get the most out of the final quarter of 2022 and be ready for new and follow-up meetings in January. We are offering a super discount bundle package for RESI November & RESI JPM San Francisco.

Bundle Package Earlybird Offer – Digital RESI November + RESI JPM San Francisco

By Candice He, Vice President of Business Development, Global Investment Strategist, LSN

Last month, Life Science Nation (LSN) was honored to collaborate with The National Institute on Aging to provide our newest entrepreneurial course to the 20 finalists of the Healthy Aging Start-Up Challenge. The course consists of two pre-course digital sessions and two in-person days leading up to RESI Boston, which helped prepare the participants for global partnering initiatives.

The program started with two 2-hour pre-course virtual sessions, aiming to introduce the timeline, required tools, and materials of a fundraising campaign, as well as the fundamental knowledge of different types of investors and strategies for successful partnering.

The 2-Day Entrepreneurial Immersion Course, hosted at the Boston Marriott Copley Place, was delivered by LSN faculty and invited industry experts. The cohort received step-by-step instructions on managing global investor target lists and fundraising campaigns, and had interactive exercises on practicing tagline and elevator pitches with their mentors face-to-face, which motivated the innovators to polish their pitch with prompt guidance.

A Shark Tank exercise concluded the course with each finalist delivering their pitch presentations to an investor panel of five, each with rich experience in the early-stage life science arena. Both NIA team and the entire faculty was highly impressed by how much the messaging had improved since the first day. Benefitting from the real-time feedback, many finalists considered the Shark Tank a vital rehearsal exercise before heading to RESI for investor meetings.

Feedback from the cohort of the NIA startup challenge:

“This was an amazing course. We had the opportunity to revise our tagline and elevator pitch with the feedback of our colleagues. We learned about various important topics related to launching a company. The mentors provided the support and guidance that we needed to keep improving and bring our innovation to life.” 

“The RESI Conference was great for me. I casually met very impressive people in the digital health field, in the legal field, and in the venture capital field. I presented in the digital health group. The partnering platform was good to use to lead folks towards my startup as a bridge to a greeting. The platform itself also was structural in my approach to meet potential investors as a warm introduction. The platform was mentally structural in helping arrange my future fundraise.” 

Transitioning from the world of academia to business is never easy, but the process can be efficient with directions from experts on what to expect and how to proceed. LSN continues building bridges between scientists and CEOs by offering more Entrepreneurial Courses to incubators, accelerators, and non-profit organizations worldwide. Contact us to learn more!

By Rory McCann, Director of Marketing & Conference Producer, LSN

Given the very recent success of Life Science Nation (LSN)’s first in-person event in 2+ years, RESI Boston, the demand for early-stage life science partnering opportunities is higher than ever. LSN’s pivot to digital events proved that there is a need for virtual partnering to accommodate the high volume of deals in the sector with limited logistics. However, there is no replacement for a face-to-face meeting or connections over coffee. Therefore, LSN continues to develop both hybrid and virtual events, and is offering a special deal on both!

RESI San Francisco, January 10-12, 2023 is our return to the West Coast for a 3-day hybrid experience. In-person RESI kicks us off the first day, featuring expert panels, educational workshops, and the Innovator’s Pitch Challenge. This is followed by an additional two days of virtual partnering to accommodate the hustle and bustle of healthcare’s biggest partnering week of the year. Fundraising doesn’t start and stop with partnering events, which is why we are bundling Digital RESI, November 15-16 and RESI San Francisco registrations to enable continuous connections through the end of the year and the beginning of next.

Startups and Service Providers can save $1,000 on their bundle when they register by October 21. We hope you’ll join us and take advantage of the opportunity to maximize your fundraising efforts and meet with investors and strategic partners who are a fit for your product and stage of development. Bundle and save by October 21 for both Digital RESI November and RESI San Francisco!

By Antoinette Lowre, Manager of Business Development, LSN

Digital RESI, November 15-16, 2022 is a virtual-only dedicated partnering event designed to facilitate well-fitting meetings through matching attendees based on product and stage of development. What sets Digital RESI dedicated partnering apart from the Digital RESI 3-Day events and Hybrid RESIs is the focus on virtual partnering. Digital RESI is designed to make partnering between major events simpler by connecting startups with investors and channel partners who are a fit for their product and stage of development.

Digital RESI can be optimized without travel and at a reasonable rate for busy early-stage entrepreneurs. View a tutorial of the partnering platform here! The super early bird rates end tomorrow, Friday, October 7. Early-stage startups can save $300 when they register by tomorrow!

By Claire Jeong, Chief Conference Officer, Vice President of Investor Research, Asia BD, LSN

Last week, we organized a very successful multi-day Redefining Early Stage Investments (RESI) event, which was our first in-person event in 2+ years! At RESI Boston, we had 61 companies participate in the Innovator’s Pitch Challenge (IPC). These finalist companies pitched to a judging panel and a full audience and exhibited a poster showcasing their technology. All attendees were provided with “RESI Cash” to vote for their favorite innovators.

RESI Boston 2022 Innovator’s Pitch Challenge Winners

1^st Place – Suma

Denice Wharton, Founder/CEO of Suma

Suma is an online management system that simplifies and streamlines the licensing and renewal process for medical professionals. Initially, our product will target workers that have an increased labor market dropout risk yet are in high demand, highly diverse and have high care impact. Certified Nurse Assistants (CNA) and Home Health Aides (HHA) provide basic direct patient care, measure vitals and help patients with activities of daily living (ADL) such as feeding, grooming, bathing, etc. They work predominantly in nursing homes, home health agencies, hospitals, and other long-term care settings caring for the elderly, sick and/or disabled. These positions are held mostly by people of color, women, immigrants, low income and at-risk populations, and are considered entry-level nursing positions. There is an overwhelming need for these healthcare workers nationwide and creating an easy way to maintain their employment will provide resources for our economy and save businesses thousands of dollars every year.

2^nd Place – Leuko Labs

Carlos Castro Gonzalez, CEO of Leuko Labs

Leuko is an MIT spinout developing PointCheckTM, the world’s first medical device that can monitor white blood cells non-invasively. By enabling more frequent at-home monitoring, Leuko aims to improve clinical outcomes for more than 2M cancer chemotherapy patients a year, reduce their chemotherapy-related hospital readmissions by 50% and save >$6B annually in healthcare cost.

3^rd Place – RudaCure

Yong Ho Kim, CEO of RUDACURE

RudaCure is a clinical stage bio-pharmaceutical start-up founded in 2018 and based in South Korea that is developing medicines for incurable diseases based on the most advanced life-science technologies to help improve human lives. By developing treatment techniques for intractable and incurable diseases, RudaCure will solve its unmet needs and treat the physical and mental pain for patients suffering from them. With creative pharmaceutical development and biomedical research, RudaCure is on the path to grow into a global pharmaceutical company.

Current main products in development include RCI001 for dry eye disease, which is in pre-IND phase and awaiting to start Phase 2 FDA clinical trials next year. RudaCure also plan to secure additional indications for RCI001 including conjunctivitis, keratitis and corneal ulcers. Second in development is RCI002, which is a non-opioid treatment for neuropathic and chronic pain currently in optimization stage. Other early stage products in development include treatments for atopic dermatitis, metastasis and CRPS.

Since April of 2021, RudaCure has successfully licensed-out RCI001 to Hanlim Pharm for domestic rights in a $12 million deal, and is currently looking for more investors and partners to license-out for international markets. Helping RudaCure along the way, are start-up accelerators MassChallenge and Shinhan Square Bridge, which are both helping RudaCure enter the US market.

By Alexander Vassallo, Manager of Business Development West Coast (US), Entrepreneurial Education Lead, LSN

With over 2,700 early-stage fundraising executives, active investors, strategic partners, and licensing collaborators having attended RESI events in 2022, Life Science Nation (LSN) is proud to announce the opening of our final partnering event for the year – Digital RESI November. Over the course of two days of dedicated virtual partnering November 15-16, Digital RESI November will serve as an exciting platform for innovative technology assets to be met with active capital and professional services.

The format for Digital RESI November will differ slightly from previous editions of the partnering conference. The two days will be purely dedicated to partnering, as the Innovator’s Pitch Challenge (IPC) and our industry-standard panels, workshops, and content will rejoin RESI in January, 2023 as RESI heads to San Francisco for JPM week. All attendees will have access to 96 30-minute slots during the two-day partnering conference with which they can continue the conversation with existing partners and establish the dialogue with new ones.

As LSN once again welcomes life science startups (across the domains of therapeutics, medical devices, diagnostics, and digital health) looking for capital and partners, active investors looking for novel technology assets, and strategic partners looking for exciting companies to add to their portfolio to the RESI platform this November, we would also like to take the time to thank the 2,700+ attendees who have previously attended RESI this year. We are proud to have facilitated the growth of the global early-stage life science sector and look forward to seeing you all virtually for the final partnering event of 2022.

SAVE $300 on Super Early Bird Rates by Friday, October 7.